Pathophysiology of involuntary emotional expression disorder

CNS Spectrums

Volumn 12, Issue 4 SUPPL. 5, 2007, Pages 17-22

  Rabins, Peter V ^a   Arciniegas, David B ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c HealthONE Spalding Rehabilitation Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CITALOPRAM; DESIPRAMINE; DEXTROMETHORPHAN; DOPAMINE RECEPTOR; FLUOXETINE; GLUTAMATE RECEPTOR; IMIPRAMINE; MEMANTINE; NEUROTRANSMITTER; PAROXETINE; SEROTONIN RECEPTOR; SERTRALINE; SIGMA OPIATE RECEPTOR;

BRAIN STEM; DOPAMINERGIC NERVE CELL; EMOTION; EMOTIONAL DISORDER; HUMAN; HYPOTHESIS; INVOLUNTARY EMOTIONAL EXPRESSION DISORDER; MEDICAL RESEARCH; NEUROANATOMY; NEUROCHEMISTRY; PATHOGENESIS; PATHOLOGICAL CRYING; PATHOLOGICAL LAUGHTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEROTONINERGIC NERVE CELL;

EID: 34248218245     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900025979     Document Type: Review

References (46)

1. Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr. 2006;11:1-7.
2. Lang PJ, Davis M. Emotion, motivation, and the brain: Reflex foundations in animal and human research. Prog Brain Res. 2006;156:3-29.
3. Anders S, Lotze M, Erb M, Grodd W, Birbaumer N. Brain activity underlying emotional valence and arousal: a response-related fMRI study. Hum Brain Mapp. 2004;23:200-209.
4. Loeb C, Poggio GF. Neural substrates of memory, affective functions, and conscious experience. Adv Anat Embryol Cell Biol. 2002;166:1-111.
5. Posse S, Fitzgerald D, Gao K et al. Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. Neuroimage. 2003;18:760-768.
6. El Falougy H, Benuska J. History, anatomical nomenclature, comparative anatomy and functions of the hippocampal formation. Bratisl Lek Listy. 2006;107:103-106.
7. Sinha R, Lacadie C, Skudlarski P, Wexler BE. Neural circuits underlying emotional distress in humans. Ann N Y Acad Sci. 2004;1032:254-257.
8. Quirk GJ, Gehlert DR. Inhibition of the amygdala: key to pathological states? Ann N Y Acad Sci. 2003;985:263-272.
9. Davidson RJ, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci. 1999;3:11-21.
10. Pelletier M, Bouthillier A, Levesque J, et al. Separate neural circuits for primary emotions? Brain activity during self-induced sadness and happiness in professional actors. Neuroreport. 2003;14:1111-1116.
11. Parvizi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying. A link to the cerebellum. Brain. 2001;124:1708-1719.
12. Zhu JN, Yung WH, Kwok-Chong CB, Chan YS, Wang JJ. The cerebellar-hypothalamic circuits: potential pathways underlying cerebellar involvement in somatic-visceral integration. Brain Res Brain Res Rev. 2006;52:93-106.
13. Pile A, Nowak G. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs Today (Barc). 2005;41:755-766.
14. Nutt D, Argyropoulos S, Hood S, Potokar J. Generalized anxiety disorder: a comorbid disease. Eur Neuropsychopharmacol. 2006;16(suppl 2):S109-S118.
15. Bijl D. The serotonin syndrome. Neth J Med. 2004;62:309-313.
16. Lopez-Garcia JA. Serotonergic modulation of spinal sensory circuits. Curr Top Med Chem. 2006;6:1987-1996.
17. Abrams JK, Johnson PL, Hollis JH, Lowry CA. Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci. 2004;1018:46-57.
18. Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience. 2006;140:1067-1077.
19. McKenna JT, Vertes RP. Collateral projections from the median raphe nucleus to the medial septum and hippocampus. Brain Res Bull. 2001;54:619-630.
20. Waselus M, Galvez JP, Valentino RJ, Van Bockstaele EJ. Differential projections of dorsal raphe nucleus neurons to the lateral septum and striatum. J Chem Neuroanat. 2006;31:233-242.
21. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience. 2002;111:815-835.
22. Glickstein SB, Schmauss C. Dopamine receptor functions: lessons from knockout mice [corrected]. Pharmacol Ther. 2001;91:63-83.
23. O'Donnell P. Dopamine gating of forebrain neural ensembles. Eur J Neurosci. 2003;17:429-435.
24. Spitzer M, Neumann M. Noise in models of neurological and psychiatric disorders. Int J Neural Syst. 1996;7:355-361.
25. Richelson E. The pharmacology of antidepressants at the synapse: focus on newer compounds. J Clin Psychiatry. 1994;55:34-41.
26. Zubieta JK, Ketter TA, Bueller JA, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry. 2003;60:1145-1153.
27. Su TP, Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem. 2003;10:2073-2080.
28. Stahl SM. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. CNS Spectr. 2005;10:319-323.
29. Arciniegas DB, Lauterbach EC, Anderson KE, et al. The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Roundtable monograph supplement. CNS Spectr. 2005;10:1-14.
30. Panitch HS, Thisted RA, Smith RA, et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol. 2006;59:780-787.
31. Wilson SAK. Some problems in neurology. No. II. - Pathological laughing and crying. J Neurol Psychopathol. 1924;IV:299-333.
32. Tateno A, Jorge RE, Robinson RG. Pathological laughing and crying following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2004;16:426-434.
33. Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry. 2000;5:290-306.
34. Lauterbach EC, Schweri MM. Amelioration of pseudobulbar affect by fluoxetine: possible alteration of dopamine-related pathophysiology by a selective serotonin reuptake inhibitor. J Clin Psychopharmacol. 1991;11:392-393.
35. Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63:1364-1370.
36. Andersen G, Ingeman-Nielsen M, Vestergaard K, Riis JO. Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission. Stroke. 1994;25:1050-1052.
37. Derex L, Ostrowsky K, Nighoghossian N, Trouillas P. Severe pathological crying after left anterior choroidal artery infarct. Reversibility with paroxetine treatment. Stroke. 1997;28:1464-1466.
38. Murai T, Barthel H, Berrouschot J, et al. Neuroimaging of serotonin transporters in post-stroke pathological crying. Psychiatry Res. 2003;123:207-211.
39. Kim SW, Shin IS, Kim JM, Lim SY, Yang SJ, Yoon JS. Mirtazapine treatment for pathological laughing and crying after stroke. Clin Neuropharmacol. 2005;28:249-251.
40. Mesulam M. Attentional networks, confusional states, and neglect syndromes. In: Mesulam M, eds. Principles of Behavioral and Cognitive Neurology. Oxford University Press; 2000:174-256.
41. Rogawski MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability. Amino Acids. 2000;19:133-149.
42. Narita N, Hashimoto K, Tomitaka S, Minabe Y. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol. 1996;307:117-119.
43. Klein M, Musacchio JM. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J Pharmacol Exp Ther. 1989;251:207-215.
44. Tortella FC, Pellicano M, Bowery NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci. 1989;10:501-507.
45. Bermack JE, Debonnel G. The role of sigma receptors in depression. J Pharmacol Sci. 2005;97:317-336.
46. Yamamoto H, Yamamoto T, Sagi N, et al. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site. J Neurosci. 1995;15:731-736.